Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...

Researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery.

Women with an age at first birth younger than 26 or older than 35 years have a higher risk for developing rheumatoid arthritis later in life.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.